INTRODUCTION
Tissue (1) (2) (3) (4) (5) (6) and alveolar (7, 8) macrophages have surface receptors that facilitate the uptake and clearance of proteases from the extracellular space. Previous studies of' pancreatic and bacterial proteases indicated that this receptor system is operative only when the proteases are complexed with alpha2 macroglobulin. However, macrophages have been found to be responsible for uptake and clearance of' certain lysosomal glycosidases (9) (10) (11) anid lactoferrin, a neutrophil granule-associated protein (12, 13) , by means of' direct binding of' these glycoproteins to cell surf:ace receptors.
Recently, it was shown that immuniioreactive human leukocyte elastase (HLE)' appears within alveolar inacrophages within minutes after intratracheal instillation (14, 15) . Because macroglobulin is absent or present in low concentrations in bronchoalveolar lining fluid (16) , and because HLE is not immunoreactive when comiplexed with alpha2 macroglobulin (17) , finding HLE within alveolar machrophages by an immunologic techni(lue suggested that these cells might bind neutrophil elastase without a re(luirement for prior association with macroglobulin. Thus, it appeared possible that miacrophage uptake of this neutrophil enzyme might be different from that for the pancreatic and bacterial proteases previously studied.
The present work provides evidence for a receptormediated clearance mechanism for HLE by human alveolar macrophages. This pathway for uptake of HLE may be particularly important in sites having low concentrations of alpha2 macroglobulin, such as the bronchoalveolar lining and the interstitial space of the lung.
METHODS
Reagents. N-a-p-tosyl-L-lysine chloromethyl ketone (TLCK), a-N-benzyl-DL-arginine-p-nitroanilide HC1 (BAPNA), soybean trypsin inhibitor, lima bean trypsin inhibitor, EDTA, phenylmethylsulfonylfluoride (PMSF), glucose oxidase, Sepharose 4B-200, yeast mannan, and CM-Sephadex were purchased from Sigma Chemical Company, St. Louis, Mo. Succinyl-L-alanyl-L-alanyl-L-alanine-p-nitroanilide (SLAPN) was purchased from Bachem, Inc., Torrance, Calif. The lactoperoxidase used was a product of Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif. 125I-NaI (11-17 mCi/,Lg) was purchased from Amersham Corp., Arlington Heights, Ill. Bio-Gel A-5m was obtained from Bio-Rad Laboratories, Richmond, Calif. Proteins. Porcine pancreatic elastase (PPE), porcine pancreatic trypsin (PPT), and bovine serum albumin (BSA) were purchased from Sigma Chemical Co.
HLE was purified from human neutrophils obtained by leukapheresis of a single volunteer, using Trasylol-Sepharose chromatography (18) . Both the amino acid composition as determined with a Beckman 1 19C amino acid analyzer (Beckman Instruments, Inc., Palo Alto, Calif.) and the electrophoretic properties by disc gel electrophoresis in 7.5% acrylamide at pH4 of the purified HLE corresponded closely to published reports for HLE (18, 19) .
Human pancreatic elastase (HPE) was kindly purified by P. Heubner by ion exchange chromatography, followed by affinity chromatography with lima bean trypsin inhibitor as the binding ligand,3 from pancreatic tissue obtained at autopsy.
Radiolabeling ofproteins. Radioiodination of HLE, HPE, PPE, PPT, and BSA was achieved using a modification of the lactoperoxidase method described by Marchalonis (20) . 200 ,ug of each purified protein was mixed with 10 ,Ag of lactoperoxidase, 300 ,uCi 1251-NaI, and 150 ig dextrose in a total volume of 150 gl phosphate-buffered saline (PBS: 50 mM 2 Kaplan, J., and M. Nielsen. 1979 . Analysis of macrophage surface receptors. I. Binding of a-macroglobulin-protease complexes to rabbit alveolar macrophages. J. Biol. Chem.
In press. 3Heubner, P. Purification of human pancreatic elastase:
the enzymatic activity wvith human elastin. Submitted for publication.
phosphate, 0.9% wt/vol NaCl, pH 7.4). After 1 h at room temperature, 160 Mug sodium metabisulfite, 250 ,g potassium iodide, and 1.5 mg BSA were added, and the total volume was brought to 1 ml with PBS. This mixture was dialyzed against several changes of PBS at 4°C until the dialysate contained <500 cpm/ml. Typically, the radiolabeled proteins contained 750,000 cpm '25I/mg. They were stored at 4°C and used within 4 wk of preparation. Preparation of inactivated HLE. To inactivate HLE, the enzyme was exposed to the serine protease inhibitor PMSF, essentially as described by Polgar and Bender (21) . PMSF completely inactivated the HLE, as measured by inability to hydrolyze SLAPN (22) , even after prolonged incubation. The inactive HLE was dialyzed against PBS to remove unreacted PMSF. To prepare inactive 1251-HLE, the enzyme was exposed to PMSF after iodination.
Alveolar macrophages. Alveolar macrophages were obtained from healthy volunteers by transbronchoscopic lavage of a basilar segment of the right lower lobe (23) . To increase the yield of macrophages, only smokers (from one-half to three packs of cigarettes daily) were selected. After collection, the chilled cells were centrifuged at 500 g at 4°C for 10 min and then washed three times with cold NTM. The final suspension, at the desired cell concentration, was kept at 4°C for immediate use. Viability of the freshly collected cells, estimated by trypan blue dye exclusion, was >95%.
Cell binding of HLE and other proteins. 4 ml of cell suspension containing 5 x 106 macrophages/ml in NTM were transferred to conical centrifuge tubes, which were continuously shaken at 37°C or at 4°C. Radiolabeled protein (HLE, HPE, PPE, PPT, or BSA) was added, to a final concentration of 2 yg/ml. To determine the total radioactive counts per unit volume of suspension, three 100-,l aliquots were immediately pipetted into 400-,ul microfuge tubes In later experiments, to eliminate need for repeated washing, the aliquots of cell suspensions were layered over 50 Al of an inert oil (Versilube F50, specific gravity 1.05, General Electric Co., Schenectady, N. Y.). Centrifugation of these tubes for 20 s resulted in sedimentation of the cells through the oil with a clean separation from the aqueous phase. The tips of the microfuge tubes, containing the cell pellets, were cut off with a razor blade and counted.
Nonspecific binding of the radiolabeled proteins to alveolar macrophages was esimated in each experiment from the binding to a parallel suspension of erythrocytes (RBC), as outlined by Debanne et al. (7, 8) . The nonspecific binding of HLE averaged 6% at 37°C in the absence oi serum and increased minimally with time. All data presented have been corrected for this nonspecific binding.
Effect ofdivalent cation. The macrophages and reference RBC were held in HBSS, (calcium and magnesium free), containing 1 mM EDTA, and washed twice more with alveolar macrophages for 30 min at 37°C. TLCK, dissolved in NTM, was then added to achieve a final concentration of 3 mg/ml. This concentration of TLCK completely inhibited the activity of the trypsin against BAPNA, but did not affect binding of HLE to the cells. 1251-HLE was then added, to a final concentration of 2 Ag/ml. Triplicate assays were performed. After a 30-min incubation at 37°C, the cellassociated radioactivity was measured.
Effect of serum protease inhibitors, mannan, and bronchoalveolar lavage fluid on binding of HLE. Pooled human serum, 10% vol/vol, was added to the cell suspensions. An '25I-HLE binding assay was then performed as previously described, and the effect of serum was compared to that produced by an equal volume of added PBS.
An alveolar macrophages and '251-HLE (final concentration, 2 ,ug/ml) in microfuge tubes containing 50 ,ul of Versilube F50. Binding of the radiolabeled HLE was determined as before, after an incubation for 30 min at 4°C. The adherence of label to the macrophages in the presence of' 195 ug/ml of unlabeled HLE was only 0.9% greater than that to RBC in the absence of unlabeled enzyme. We considered this amount to be nonspecific binding. In each case, therefore, the inhibition of binding produced by 195 ,ug/ml of unlabeled HLE was defined as 100%.
Saturability, affinity, and receptor number. Binding assays were performed as described above, except that the macrophage number was reduced to 105 cells/assay, the incubation time was 10 min, and the '251-HLE concentration in the assay was varied.
High-resolution autoradiography. Macrophages incubated with '251-HLE in suspension for 5, 10, and 120 min were pelleted in microfuge tubes, washed by resuspension in PBS three times, and the final pellet fixed f'or 1 h with 3% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.3. The pellets were rinsed with PBS, fixed again for 1 h in 1% osmium tetroxide in cacodylate buffer, and embedded in epoxy resin.
Thin (800 A) sections were mounted on 300 mesh grids, coated with Ilford L-4 nuclear tract emulsion (Ilford Ltd., Essex, England) by the loop technique (24) , and exposed in light-tight boxes for 2 mo at 4°C. The grids were developed for 5 min with Microdol-X (Eastman Kodak Co., Rochester, N. Y.), fixed in Kodak rapid fixer, and rinsed in five changes of distilled water. The emulsion was removed with 0.05N NaOH and the grids stained with uranyl acetate and lead citrate. Electron micrographs were made of 50 consecutive labeled cells for each time interval and printed at a final magnification of x 13,000.
To localize the enzyme within the cells, the center of each grain was marked using a transparent overlay on which a circle 1 cm in diameter was transcribed. A 1-mm hole was made in the overlay at the center of the circle. The circle was centered around each grain and a pinhole made in the micrograph through the hole in the overlay. This pinhole was taken as the center of' the grain. The grains were tabulated according to the structures in which the pinhole occurred. The organelles used for the tabulation were nuclei, mitochondria, granules (lysosomes), vacuoles, and cytoplasm (vhich included endoplasmic reticulum). The vacuoles were f'ound almost exclusively in the peripheral cytoplasm near the plasma membrane, and were presumed to be endocytic vacuoles.
To determine whether label was selectively concentrated in a given organelle, chi-square analysis was used to compare the number of grains observed over that organelle to the number of grains expected assuming a uniform concentration of label in all cellular structures. For each time period, the number of expected grains for each organelle was calculated by multiplying the total number of grains found over cells by the volume density (volume fraction) for that organelle. The volume density of each type of organelle was determined on 10 electron micrographs from each time interval by point counting, with a transplant overlay that provided 980 points/ micrograph.
RESULTS
Radiolabeled proteins. Purified HLE migrated as a series of isozymes with slightly different electrophoretic mobility, as found by others (18, 19) . The electrophoretic migration of' HLE was unchanged by the labeling procedure, as shown in Fig.l . Radiolabeled HLE comigrated with freshly purified unlabeled HLE. Typically, 80% of the HLE activity against SLAPN remained after radiolabeling. Greater than 95% of' the radioactivity of each radiolabeled protein was precipitable by 10% TCA.
Binding of HLE to human alveolar macrophages. When 1251-HLE was incubated with alveolar macrophages at 37°C in NTM, a rapid initial phase of binding was observed (Fig. 2) . In the experiment shown, 48% of the radiolabel was bound to the cells within 30 min at 37°C. After this time, a slow linear increase in cell-associated radiolabel was observed, which averaged m1.5%/h over many observations. Similar binding occurred during the first 10 min of incubation (Fig. 3) Binding ofinactivated HLE. The binding of '25I-HLE that had been inactivated with PMSF was indistinguishable from that of active HLE (Fig. 4) Complexes of active HLE with alpha2 macroglobulin did bind, although to a lesser extent than free HLE. Bronchoalveolar lavage fluid from a smoker, concentrated x10, prevented binding of active, but not of PMSF-inactivated, HLE to macrophages. This demonstrated that the fluid contained inhibitory activity against HLE capable of complexing with active HLE and preventing its binding (Table I ). The inhibitor was not identified.
Yeast mannan failed to alter the binding of active or PMSF-inactivated HLE (Table I) .
Inhibition ofbinding by unlabeled elastases. Active, unlabeled HLE produced a concentration-dependent inhibition of binding of radiolabeled HLE (Fig. 6 ). In°O A Scatchard plot of' the data (Fig. 8 ) allowed the total number of' binding sites to be estimated as 640 x 106/macrophage. The association constaint for the binding reaction was estimated from the slope of' the Scatchard plot to be 4.97 x 10W M-1.
Autoradiography. Background labeling (grains over empty resin) was negligible. After 5 and 10 min of' incubation, grains tended to be at the periphery of' the cell, whereas at 2 h the label was found throughout the cytoplasm. The nucleus and mitochondria were nearly free of grains at all time periods (Table II) . At 5 min, the label was concentrated in the endocytic vesicles (P < 0.001), although some label was associated with lysosomal granules (P < 0.05). At 10 min both granules and vacuoles were labeled (P < 0.001), buit at 2 h only the lysosomal granules (Fig. 9) were significantly labeled (P < 0.001). Calculation of grain density (grains/unit area) showed progressive accumulation of' label in the lysosomal granules with time (Table II) .
DISCUSSION
The work described in this report demonstrates that HLE binds rapidly and specifically to alveolar 20 The binding of HLE to macrophages is distinct from the receptor-mediated binding of mannose or N-acetyl glucosamine-terminal glycoprotein lysosomal enzymes to macrophages (10, 11), which are responsible for in vivo clearance of these substances from the extracellular space (25) (26) (27) (28) (29) (30) . This distinction is demonstrated by the trypsin insensitivity of binding of HLE, by the lack of requirement for divalent cation, and by the failure of yeast mannan to inhibit binding.
It is known that macrophages bind lactoferrin (12, 13), another neutrophil granule-associated glycoprotein (31, 32) . Hepatocyte receptor recognition of lactoferrin (33) , and macrophage recognition of lysosomal glycosidases (11) , and probably also the Fc portion of immunoglobulin (Ig)G (34) , are mediated by sugar residues on these ligands. HLE is a glycoprotein (39, 40) , and also locally produced inhibitors such as those present in bronchoalveolar lining fluid (41, 42) . Alpha, antitrypsin, however, is slowly hydrolyzed by the elastase with which it is complexed, releasing active enzyme (40, 43, 44) . Proteases bound to alpha2 macroglobulin retain activity against a range of substrates, particularly those of low molecular weight, while being protected from large molecular weight inhibitors (39, (45) (46) (47) (48) .
Although protease inhibition provides immediate partial or complete inactivation of extracellular HLE, ultimate disposal depends upon intracellular degradation. HLE (6), PPT (1, 2, 7, 8) , PPE (5), alphachymotrypsin (3), subtilisin A (4), and presumably all endopeptidases that are inhibited by alpha2 macroglobulin, bind to macrophages after they have formed complexes with macroglobulin. Binding ofthe complexes results in rapid clearance of the proteases from the extracellular space, and is followed in vivo by their degradation. It is particularly noteworthy that 1251-HLE injected intravenously in man is cleared from the circulation in the form ofenzyme-alpha2 macroglobulin complexes, with localization of the radiolabel over the liver, then appearance in dialyzable form in the urine (6) . No corresponding clearance mechanism for alpha, antitrypsin complexes exists.
These data have led to the view that alpha2 macroglobulin binding is an important step leading to cellular degradation of proteases. In previous in vitro studies that established this mechanism, uncomplexed enzymes did not bind to macrophages; but all previous work looking for such binding utilized enzymes of bacterial or pancreatic, and not neutrophil, origin.
This work agrees that the pancreatic proteases tested (PPT, PPE, and HPE) do not specifically bind to macrophages. It has already been established that differences in structure (18) , immunoreactivity (18) , and activity (6, 49) exist between pancreatic and neutrophil elastases. This study indicates yet another difference between the elastases from the two sources. The work described in this report also agrees that HLE complexed with alpha2 macroglobulin, but not with alpha1 antitrypsin, binds to macrophages. It is known that if a small amount of HLE is added to serum, 92% of the enzyme binds to alpha1 antitrypsin, whereas only 8% binds to alpha2 macroglobulin (40) . This presumably explains the low binding of 1251-HLE observed in this report when serum was present, although an additional unidentified factor(s) in serum also decreases binding, because the binding of PMSFinactivated HLE is decreased by serum but not by purified alpha1 antitrypsin.
The findings reported here provide evidence for an alternative pathway for cellular clearance of HLE, that of direct binding and internalization of the active enzyme. These data also permit estimation of the capability of macrophages to bind the HLE released by neutrophils in response to physiologic stimuli. Published data (38) show that 5 x 106 neutrophils release 22 ,Ag of HLE (78 x 106 molecules/cell) in response to an immunologic stimulus in vitro. Based upon our estimated total number of binding sites, each macrophage has the capacity to bind the HLE released by eight neutrophils.
A previous report from this laboratory presented evidence that alveolar macrophages harvested from cigarette smokers released elastolytic activity into serum-free culture media (23) . One hypothesis as to the origin of the elastase was that it represented leukocyte elastase that was associated with the harvested macrophages and that was then released in vitro, either spontaneously or as a consequence of macrophage death. This report lends credibility to that hypothesis by demonstrating that leukocyte elastase binds to alveolar macrophages.
High-resolution autoradiography in the present study showed that bound radiolabeled HLE was rapidly internalized and progressively incorporated into phagolysosomes. Although our analysis of the fate of internalized HLE is continuing, data thus far suggest that the majority of the internalized enzyme is degraded intracellularly.
The 
